Fast, local cryopreservation is a consistent bottleneck for autologous cell therapy developers, even in major cell and gene therapy hubs.
New MIOSHA standard adds stricter inspection and worker training mandates with enforcement delayed until September.
The Trusted Exchange Framework and Common Agreement Recognized Coordinating Entity published updated standard operating procedures for the individual access services exchange protocol and new FAQs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results